Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of administering inhibitory anti-factor XII/XIIa monoclonal antibodies

Methods of administering inhibitory anti-factor XII/XIIa monoclonal antibodies

US Patent 11345759 · Granted May 31, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods to improve exercise performance and recovery2024
Nucleic acids encoding antibodies against human granulocyte-colony stimulating f2024
Nucleic acids encoding antibodies against human granulocyte-colony stimulating f2024
Therapy using a factor XII inhibitor in a neurotraumatic disorder2024
CD131 binding proteins and uses thereof2023
CD131 binding proteins and uses thereof2023
Use of a FXIIa-inhibitor in the treatment of renal fibrosis and/or chronic kidne2022
Use of a FXIIa-inhibitor in the treatment of renal fibrosis and/or chronic kidne2022
Human serum albumin variants and uses thereof2022
Method of treating atherosclerosis2021
Treatment and prevention of remote ischemia-reperfusion injury2021
CD131 binding proteins2021